Form 4: Hinge Health CFO Reports Stock Transaction

Hinge Health, Inc. Chief Financial Officer, James Budge, reported a transaction involving Class A Common Stock on May 1, 2026.

Summary

• James Budge, Chief Financial Officer of Hinge Health, Inc., reported a transaction on May 1, 2026.
• The transaction involved the disposal of 4,614 shares of Class A Common Stock.
• These shares were relinquished by Mr. Budge and cancelled by the Issuer to cover federal and state tax withholding obligations related to the vesting of restricted stock units.
• Following this transaction, Mr. Budge beneficially owns 392,199 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the stock disposal is a routine event for covering tax obligations and does not necessarily indicate a change in the executive's long-term view of the company.

Positives

• The transaction was an exempt transaction under Section 16b-3(e), related to the payment of tax liabilities.
• Mr. Budge continues to hold a significant number of shares (392,199) directly, indicating continued beneficial ownership.

Negatives

• The disposal of shares, even for tax purposes, represents a reduction in the number of shares held by a key executive.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Management Comments

• All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and are closely watched by investors to gauge executive confidence and potential shifts in beneficial ownership. This specific transaction relates to the common practice of executives using vested equity to cover tax liabilities.

Stakeholder Impact

• Shareholders: The transaction does not directly impact the number of shares outstanding or the company's financial performance, but it is a routine disclosure that may be monitored for insider activity.

Key Dates

Keywords

Hinge Health, HNGE, Form 4, Stock Transaction, Beneficial Ownership, Class A Common Stock, Restricted Stock Units, Tax Withholding, Executive Compensation